The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Cryptococcal meningitis
Abstract
Cryptococcal meningitis is a common opportunistic infection in AIDS patients, particularly in Southeast Asia and Africa. Cases also occur in patients with other forms of immunosupression and in apparently immunocompetent individuals. Mortality from HIV-associated cryptococcal meningitis remains high (10-30%), even in developed countries, because of the inadequacy of current antifungal drugs and the complication of raised intracranial pressure. In cohorts of HIV-infected patients from sub-Saharan Africa, cryptococcosis has accounted for 13-44% of all deaths. Optimal current therapy is with amphotericin B 0.7-1 mg/kg/day plus flucytosine 100 mg/kg/day for 2 weeks, followed by fluconazole 400 mg/day for 8 weeks and 200 mg/day thereafter. Saline loading reduces amphotericin B nephrotoxicity. If there is no contraindication on CT head scan, repeat lumbar puncture with drainage of cerebrospinal fluid (CSF) is recommended for patients with very raised CSF opening pressure. Expansion of antiretroviral programmes raises the prospect of transforming the long-term prognosis of these patients, provided that they survive the acute phase of the illness. Studies are needed to define more fungicidal drug regimens and to improve the treatment of raised intracranial pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice Guidelines for the Management of Cryptococcal Disease
Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D., Dismukes, W. E., & Mycoses Study Group Cryptococcal Subproject (2000) · Clinical Infectious Diseases · doi:10.1086/313757 · Cited by 1,105
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T., Moskovitz, B. L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370103 · Cited by 820
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
Perfect, J. R., Marr, K. A., Walsh, T. J., Greenberg, R. N., DuPont, B., de la Torre‐Cisneros, J., Just‐Nubling, G., Schlamm, H. T., Lutsar, I., Espinel‐Ingroff, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374557 · Cited by 680
Casadevall, A., & Perfect, J. R. (1998) · ASM Press eBooks · doi:10.1128/9781555818241 · Cited by 661
Pappas, P. G., Perfect, J. R., Cloud, G. A., Larsen, R. A., Pankey, G. A., Lancaster, D. J., Henderson, H., Kauffman, C. A., Haas, D. W., Saccente, M., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322597 · Cited by 642
Saag, M. S., Powderly, W. G., Cloud, G. A., Robinson, P., Grieco, M. H., Sharkey, P. K., Thompson, S. E., Sugar, A. M., Tuazon, C. U., Fisher, J. F., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260202 · Cited by 631
Prognostic Factors in Cryptococcal Meningitis: A Study in 111 Cases
DIAMOND, R. D., & BENNETT, J. E. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-2-176 · Cited by 605
Amphotericin B: current understanding of mechanisms of action
Brajtburg, J., Powderly, W. G., Kobayashi, G. S., & Medoff, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.183 · Cited by 504
Graybill, J. R., Sobel, J., Saag, M., van der Horst, C., Powderly, W., Cloud, G., Riser, L., Hamill, R., Dismukes, W., & NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups (2000) · Clinical Infectious Diseases · doi:10.1086/313603 · Cited by 486
Clinical and Host Differences Between Infections with the Two Varieties of Cryptococcus neoformans
Speed, B., & Dunt, D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.28 · Cited by 478
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A., White, N. J., & Harrison, T. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16301-0 · Cited by 470
Self-citationMirza, S. A., Phelan, M., Rimland, D., Graviss, E., Hamill, R., Brandt, M. E., Gardner, T., Sattah, M., Ponce de Leon, G., Baughman, W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/368091 · Cited by 459
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
French, N., Gray, K., Watera, C., Nakiyingi, J., Lugada, E., Moore, M., Lalloo, D., Whitworth, J. A. G., & Gilks, C. F. (2002) · AIDS · doi:10.1097/00002030-200205030-00009 · Cited by 417
Dismukes, W. E., Cloud, G., Gallis, H. A., Kerkering, T. M., Medoff, G., Craven, P. C., Kaplowitz, L. G., Fisher, J. F., Gregg, C. R., Bowles, C. A., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170602 · Cited by 417
Serologic Evidence for Cryptococcus neoformans Infection in Early Childhood
Goldman, D. L., Khine, H., Abadi, J., Lindenberg, D. J., Pirofski, L.-A., Niang, R., & Casadevall, A. (2001) · Pediatrics · doi:10.1542/peds.107.5.e66 · Cited by 413
Walsh, T. J., Goodman, J. L., Pappas, P., Bekersky, I., Buell, D. N., Roden, M., Barrett, J., & Anaissie, E. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3487-3496.2001 · Cited by 401
Larsen, R. A., Leal, M. A. E., & Chan, L. S. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-183 · Cited by 357
Epidemiological Evidence for Dormant Cryptococcus neoformans Infection
Garcia-Hermoso, D., Janbon, G., & Dromer, F. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3204-3209.1999 · Cited by 323
Powderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S. L., Eyster, M. E., Carey, J., Waskin, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321102 · Cited by 318
Casadevall, A., Cleare, W., Feldmesser, M., Glatman-Freedman, A., Goldman, D. L., Kozel, T. R., Lendvai, N., Mukherjee, J., Pirofski, L.-A., Rivera, J., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1437 · Cited by 298
Leenders, A. C. A. P., Reiss, P., Portegies, P., Clezy, K., Hop, W. C. J., Hoy, J., Borleffs, J. C. C., Allworth, T., Kauffmann, R. H., Jones, P., et al. (1997) · AIDS · doi:10.1097/00002030-199712000-00010 · Cited by 289
Hajjeh, R. A., Conn, L. A., Stephens, D. S., Baughman, W., Hamill, R., Graviss, E., Pappas, P. G., Thomas, C., Reingold, A., Rothrock, G., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314606 · Cited by 275
Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa
Holmes, C. B., Losina, E., Walensky, R. P., Yazdanpanah, Y., & Freedberg, K. A. (2003) · Clinical Infectious Diseases · doi:10.1086/367655 · Cited by 237
Casadevall, A., Steenbergen, J. N., & Nosanchuk, J. D. (2003) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(03)00082-1 · Cited by 232
Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages
Levitz, S. M., Nong, S.-H., Seetoo, K. F., Harrison, T. S., Speizer, R. A., & Simons, E. R. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.885-890.1999 · Cited by 231
Self-citationLee, S. C., Dickson, D. W., & Casadevall, A. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90459-1 · Cited by 224
Hakim, J. G., Gangaidzo, I. T., Heyderman, R. S., Mielke, J., Mushangi, E., Taziwa, A., Robertson, V. J., Musvaire, P., & Mason, P. R. (2000) · AIDS · doi:10.1097/00002030-200007070-00013 · Cited by 224
Sau, K., Mambula, S. S., Latz, E., Henneke, P., Golenbock, D. T., & Levitz, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306137200 · Cited by 216
Denning, D. W., Armstrong, R. W., Lewis, B. H., & Stevens, D. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90126-i · Cited by 205
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis
Pappas, P. G., Bustamante, B., Ticona, E., Hamill, R. J., Johnson, P. C., Reboli, A., Aberg, J., Hasbun, R., & Hsu, H. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/420829 · Cited by 202
Mwaba, P., Mwansa, J., Chintu, C., Pobee, J., Scarborough, M., Portsmouth, S., & Zumla, A. (2001) · Postgraduate Medical Journal · doi:10.1136/pgmj.77.914.769 · Cited by 198
Denning, D. W., Kibbler, C. C., & Barnes, R. A. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00580-2 · Cited by 194
Prevention of Amphotericin B—Induced Renal Impairment: A Review on the Use of Sodium Supplementation
Branch, R. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380110049010 · Cited by 194
Corbett, E. L., Churchyard, G. J., Charalambos, S., Samb, B., Moloi, V., Clayton, T. C., Grant, A. D., Murray, J., Hayes, R. J., & De Cock, K. M. (2002) · Clinical Infectious Diseases · doi:10.1086/339540 · Cited by 185
Jenny‐Avital, E. R., & Abadi, M. (2002) · Clinical Infectious Diseases · doi:10.1086/344467 · Cited by 185
Yauch, L. E., Mansour, M. K., Shoham, S., Rottman, J. B., & Levitz, S. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5373-5382.2004 · Cited by 185
Goldman, D. L., Lee, S. C., Mednick, A. J., Montella, L., & Casadevall, A. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.832-838.2000 · Cited by 177
Powderly, W. G., Cloud, G. A., Dismukes, W. E., & Saag, M. S. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.5.789 · Cited by 173
Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection
Aller, A. I., Martin-Mazuelos, E., Lozano, F., Gomez-Mateos, J., Steele-Moore, L., Holloway, W. J., Gutiérrez, M. J., Recio, F. J., & Espinel-Ingroff, A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1544-1548.2000 · Cited by 170
Lazéra, M. S., Pires, F. D. A., Camillo-Coura, L., Nishikawa, M. M., Bezerra, C. C. F., Trilles, L., & Wanke, B. (1996) · Medical Mycology · doi:10.1080/02681219680000191 · Cited by 163
Early Mycological Treatment Failure in AIDS‐Associated Cryptococcal Meningitis
Robinson, P. A., Bauer, M., Leal, M. A. E., Evans, S. G., Holtom, P. D., Diamond, D. M., Leedom, J. M., & Larsen, R. A. (1999) · Clinical Infectious Diseases · doi:10.1086/515074 · Cited by 160
Woods, M. L., MacGinley, R., Eisen, D. P., & Allworth, A. M. (1998) · AIDS · doi:10.1097/00002030-199812000-00011 · Cited by 150
Levitz, S. M., Nong, S.-H., Mansour, M. K., Huang, C., & Specht, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181331398 · Cited by 149
Chariyalertsak, S., Sirisanthana, T., Saengwonloey, O., & Nelson, K. E. (2001) · Clinical Infectious Diseases · doi:10.1086/319348 · Cited by 149
IFN-γ at the Site of Infection Determines Rate of Clearance of Infection in Cryptococcal Meningitis
Siddiqui, A. A., Brouwer, A. E., Wuthiekanun, V., Jaffar, S. S., Shattock, R. J., Irving, D., Sheldon, J., Chierakul, W., Peacock, S. J., Day, N., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1746 · Cited by 146
Self-citationDevi, S. J. (1996) · Vaccine · doi:10.1016/0264-410x(95)00256-z · Cited by 145
Mayanja‐Kizza, H., Oishi, K., Mitarai, S., Yamashita, H., Nalongo, K., Watanabe, K., Izumi, T., Ococi-Jungala, Augustine, K., Mugerwa, R. D., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516372 · Cited by 128
Bacterial Meningitis in Malawian Adults: Pneumococcal Disease is Common, Severe, and Seasonal
Gordon, S. B., Walsh, A. L., Chaponda, M., Gordon, M. A., Soko, D., Mbvwinji, M., Molyneux, M. E., & Read, R. C. (2000) · Clinical Infectious Diseases · doi:10.1086/313910 · Cited by 120
Management of Elevated Intracranial Pressure in Patients With Cryptococcal Meningitis
Fessler, R. D., Sobel, J. D., Guyot, L. L., et al. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199802010-00006 · Cited by 119
Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection
Dadachova, E., Nakouzi, A. S., Bryan, R. A., & Casadevall, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1731272100 · Cited by 107
Treatment of Hydrocephalus Secondary to Cryptococcal Meningitis by Use of Shunting
Park, M. K., Hospenthal, D. R., & Bennett, J. E. (1999) · Clinical Infectious Diseases · doi:10.1086/515161 · Cited by 104
Cryptococcal Meningitis: Outcome in Patients with AIDS and Patients with Neoplastic Disease
White, M., Cirrincione, C., Blevins, A., & Armstrong, D. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.5.960 · Cited by 100
Okongo, M. J. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.4.698 · Cited by 99
High-Dose Fluconazole Therapy for Cryptococcal Meningitis in Patients with AIDS
Menichetti, F., Fiorio, M., Tosti, A., Gatti, G., Pasticci, M. B., Miletich, F., Marroni, M., Bassetti, D., & Pauluzzi, S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.838 · Cited by 94
Primary Complex of Cryptococcus and Pulmonary Lymph Nodes
Salyer, W. R., Salyer, D. C., & Baker, R. D. (1974) · The Journal of Infectious Diseases · doi:10.1093/infdis/130.1.74 · Cited by 91
Serum Cryptococcal Antigen in Patients with AIDS
Feldmesser, M., Harris, C., Reichberg, S. B., Khan, S. M., & Casadevall, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.4.827 · Cited by 85
Amphotericin B and Fluconazole, a Potent Combination Therapy for Cryptococcal Meningitis
Larsen, R. A., Bauer, M., Thomas, A., & Graybill, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.985-991.2004 · Cited by 83
Guého, E., Improvisi, L., Christen, R., et al. (1993) · Antonie van Leeuwenhoek · doi:10.1007/bf00872392 · Cited by 83
Haubrich, R., Haghighat, D., Bozzette, S. A., Tilles, J. G., McCutchan, J. A., & California Collaborative Treatment Group (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.1.238 · Cited by 74
de Lalla, F., Pellizzer, G., Vaglia, A., Manfrin, V., Franzetti, M. M., Fabris, P., & Stecca, C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.2.263 · Cited by 66
Macsween, K. F., Bicanic, T. A., Brouwer, A. E., et al. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.02.010 · Cited by 65
Self-citationAntifungal Pharmacodynamics: Review of the Literature and Clinical Applications
Dodds, E. S., Drew, R. H., & Perfect, J. R. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.17.1335.34901 · Cited by 50
Cryptococcus Infection in Tropical Australia
Jenney, A. W. J., Pandithage, K., Fisher, D. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3865-3868.2004 · Cited by 50
Predictors of outcome in Cryptococcus neoformans var. gattii meningitis
Seaton, R. A., Naraqi, S., Wembri, J. P., & Warrell, D. A. (1996) · QJM · doi:10.1093/qjmed/89.6.423 · Cited by 49
Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients
Quagliarello, V., Viscoli, C., & Horwitz, R. I. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90465-4 · Cited by 42
Berlin, L. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520480054020 · Cited by 38
Cited by
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Rodrigues, M. L., Nakayasu, E. S., Oliveira, D. L., Nimrichter, L., Nosanchuk, J. D., Almeida, I. C., & Casadevall, A. (2008) · Eukaryotic Cell · doi:10.1128/ec.00370-07 · Cited by 558
Systematic Genetic Analysis of Virulence in the Human Fungal Pathogen Cryptococcus neoformans
Liu, O. W., Chun, C. D., Chow, E. D., Chen, C., Madhani, H. D., & Noble, S. M. (2008) · Cell · doi:10.1016/j.cell.2008.07.046 · Cited by 443
Boulware, D. R., Rolfes, M. A., Rajasingham, R., von Hohenberg, M., Qin, Z., Taseera, K., Schutz, C., Kwizera, R., Butler, E. K., Meintjes, G., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2001.130906 · Cited by 321
Chun, C. D., Liu, O. W., & Madhani, H. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030022 · Cited by 181
Metadata
- Authors
- Bicanic, T., & Harrison, T. S.
- Venue
- British Medical Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 72
- Issue
- 1
- Pages
- 99-118
- ISSN
- 0007-1420 (ISSN-L)
- 1471-8391
- OpenAlex
- W4233381066
- Cited by
- 361
- References
- 66
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.